Merge PACS vs Zio AT ECG Monitoring System
AI Verdict
Choose Merge PACS if…
Choose Merge PACS if your multi-site health system requires an enterprise-level solution to consolidate diverse imaging data, streamline radiology workflows, and integrate AI insights across multiple specialties. This tool is ideal for organizations seeking flexible deployment options (on-premise, cloud, hybrid) and enhanced diagnostic capabilities for a high volume of imaging studies.
View Merge PACS →Choose Zio AT ECG Monitoring System if…
Choose the Zio AT ECG Monitoring System if you need a reliable, wearable solution for continuous, long-term (up to 14 days) ECG monitoring to detect symptomatic and asymptomatic arrhythmias. This system is best suited for cardiologists and healthcare providers looking for an FDA-cleared, AI-powered service that provides comprehensive reports for arrhythmia diagnosis and patient management.
View Zio AT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Merge PACS | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | On-premise, Cloud, Hybrid | Cloud-based (data analytics and clinician portal) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio AT ECG Monitoring SystemZio AT's wearable patch and patient-centric design offer superior usability for patients, leading to high compliance and comfort during extended monitoring. While Merge PACS focuses on streamlining complex clinician workflows within an imaging environment, Zio AT's ease of use for both patients and clinicians in its specific domain gives it an edge in overall accessibility and patient experience.
Clinical Value
Zio AT ECG Monitoring SystemZio AT offers direct, evidence-backed clinical value through its FDA-cleared AI algorithm for continuous arrhythmia detection, which has been shown to improve diagnostic yield and patient outcomes compared to traditional methods. Clinical studies demonstrate its effectiveness in detecting actionable arrhythmias that might be missed by shorter monitoring.
Pricing & Value
Zio AT ECG Monitoring SystemAlthough both tools have opaque pricing, Zio AT has published studies demonstrating its cost-effectiveness and health economic value, showing reductions in outpatient visits, repeat testing, and potential savings in downstream procedures. Merge PACS lacks publicly available data on its cost-effectiveness or return on investment, making it difficult to assess its value beyond its features.
Enterprise Readiness
Merge PACSMerge PACS is explicitly designed as an 'enterprise-level' PACS for multi-site health systems, offering flexible deployment options (on-premise, cloud, hybrid) and extensive integration with EMR/EHR, RIS, HIS, and VNA systems. Its proven adoption by large healthcare systems and broad feature set for imaging management make it more broadly enterprise-ready than Zio AT, which is specialized for cardiac monitoring.
Innovation
Zio AT ECG Monitoring SystemZio AT's innovation lies in its novel wearable patch technology combined with an FDA-cleared, deep-learned AI algorithm for continuous, long-term cardiac monitoring, which fundamentally changes how arrhythmias are detected. This represents a more disruptive innovation in patient monitoring and diagnosis compared to Merge PACS's valuable, but more platform-oriented, AI integration capabilities.
Support & Docs
TieBoth companies appear to offer comprehensive support, including implementation, training, and ongoing technical assistance. Merative highlights 24/7 support and extensive documentation like DICOM conformance statements, while iRhythm provides dedicated customer care, patient support resources, and a robust clinical resource center. Without more detailed comparative metrics on response times, issue resolution, or user satisfaction for both, it's difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Merge PACS | Zio AT ECG Monitoring System |
|---|---|---|
| Tool Name | Merge PACS | Zio AT ECG Monitoring System |
| Primary System Type | Enterprise-level Picture Archiving and Communication System (PACS) | Wearable Mobile Cardiac Telemetry (MCT) System |
| Company | Merative | iRhythm Technologies, Inc. |
| Primary Clinical Specialties | Cardiology, Radiology | Cardiology |
| Core AI Functionality | AI integration and readiness (single worklist access to 3rd party AI applications) | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection |
| Key Monitoring/Management Aspect | Enterprise-wide image management and consolidation, enhanced diagnostic workflows | Continuous, uninterrupted ECG recording for up to 14 days, real-time data transmission |
Videos
Demos, reviews, and walkthroughs featuring Merge PACS and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Merge PACS or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.